FDA Class II Device Recall: GEM Premier 5000
Summary
The FDA has initiated a Class II device recall for Instrumentation Laboratory's GEM Premier 5000, Part No. 00055415010. The recall is due to customer complaints indicating an increased incidence of 'Process Control Solution Not Detected' errors with the GEM PAK cartridges, potentially leading to device malfunction. The product has been distributed worldwide.
What changed
The FDA has classified a recall of the GEM Premier 5000 (Part No. 00055415010) as Class II, indicating that use of or exposure to the faulty product may cause temporary or medically reversible adverse health consequences. The issue stems from GEM PAK cartridges experiencing an increased incidence of 'Process Control Solution Not Detected' errors during warm-up, which can lead to cartridge ejection and require re-insertion. This recall affects worldwide distribution, including the US and numerous other countries.
Healthcare providers using the GEM Premier 5000 should be aware of this recall and monitor for the specific error codes. While the recall is ongoing, the document does not specify immediate actions required by users beyond awareness of the potential malfunction. Compliance officers should review their inventory and consider any internal protocols for managing recalled medical devices. The FDA's classification suggests a moderate level of risk, emphasizing the need for vigilance in clinical settings.
What to do next
- Review inventory of GEM Premier 5000 and associated GEM PAK cartridges.
- Monitor for 'Process Control Solution Not Detected' errors during device warm-up.
- Consult manufacturer guidance for any specific actions related to this recall.
Source document (simplified)
Instrumentation Laboratory
Device Recalls (Class II)
← All Device Recalls (Class II) Class II Z-1535-2026 · 20260318 · Ongoing
Product
GEM Premier 5000; Part No. 00055415010.
Reason for Recall
Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...
Source: openFDA Enforcement API
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.